Bladder Cancer drug shortage resolved with Health Canada approval

TORONTO, Feb. 24, 2021 /CNW/ – Verity Pharmaceuticals Inc. is pleased to announce that it has received a notice of compliance with conditions (NOC/c) from Health Canada for the VERITY-BCG™ (Bacillus Calmette-GuĂ©rin [BCG]: Strain Russian BCG-I). This approval is welcome news for patients and health care providers who have endured a Canadian and global shortage of … Continue reading Bladder Cancer drug shortage resolved with Health Canada approval